The present invention relates to a compound according to formula (I) wherein R1 is selected from the group consisting of 5- and 6- membered heteroaryl, (C1- C6)alkyl, (C3-C6)cycloalkyl, (4-6)-membered heterocycloalkyl and phenyl; R2 is selected from (C1-C3)alkyl and halo(C1-C3)alkyl; R3 is selected from phenyl, 5-membered heteroaryl and 6-membered heteroaryl; R4 is selected from hydrogen, halogen, (C1- C4)alkyl and halo(C1-C4)alkyl; X1 is selected from CH, C(Rb) and N, X2 is selected from CH and N; Y is selected from -NH- and -O-; m is 0 or 1; n is 0 or 1; L represents a bond, -O-, -NH- or -N(RC)-; or pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention relates further to intermediates for the preparation of said compounds, to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases with said compounds, and to the use of said compounds in the manufacture of medicaments.
本发明涉及一种化合物,其
化学式为(I),其中R1选自由5-和6-成员杂芳基、(C1-C6)烷基、(C3-C6)
环烷基、(4-6)-成员杂
环烷基和
苯基;R2选自(C1-C3)烷基和卤代(C1-C3)烷基;R3选自
苯基、5-成员杂芳基和6-成员杂芳基;R4选自
氢、卤素、(C1-C4)烷基和卤代(C1-C4)烷基;X1选自CH、C(Rb)和N,X2选自CH和N;Y选自-NH-和-O-;m为0或1;n为0或1;L代表键,-O-,-NH-或-N(RC)-;或其药学上可接受的盐、
水合物或溶剂化合物。本发明还涉及用于制备所述化合物的
中间体,用于治疗的该化合物,包含该化合物的药物组合物,使用该化合物治疗疾病的方法,以及使用该化合物制造药品的用途。